SCHEMBL8972244

SCHEMBL8972244

[N]CCCCn1cnc2c(N)ncnc21

nearest known ligand 0.70

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 9/20 0.70
ADORA1 P30542 4/20 0.65
ADORA2B P29275 1/20 0.65
ADCY5 O95622 4/20 0.61
PI4KA P42356 3/20 0.59
PI4K2B Q8TCG2 3/20 0.59
PI4K2A Q9BTU6 3/20 0.59
PI4KB Q9UBF8 3/20 0.59
ALDH1A1 P00352 1/20 0.54
ADCY1 Q08828 1/20 0.54
NSD2 O96028 2/20 0.53
NSD3 Q9BZ95 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20445820 0.86 ADORA2A (0.72) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL5015473 0.86 ADORA2A (0.72) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL4906617 0.86 ADORA2A (0.72) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL11222112 0.85 ADORA2A (0.80) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL5016779 0.84 ADORA2A (0.70) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL38913 0.84 ADORA2A (0.70) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL4551803 0.84 ADORA2A (0.91) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL19553487 0.84 ADORA2A (0.91) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL5017547 0.84 ADORA2A (0.70) ADORA2AADORA1ADORA2BADCY5PI4KA
SCHEMBL2638945 0.84 ADORA2A (0.74) ADORA2AADORA1ADORA2BADCY5PI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0596802-B1 Erythromycin derivatives, their process of preparation and their application as medicaments ROUSSEL UCLAF (FR) 1996-03-20 EP disclosed
EP-0596802-A1 Erythromycin derivatives, their process of preparation and their application as medicaments ROUSSEL UCLAF (FR) 1994-05-11 EP disclosed